Workboat Indexes
Catalyst Pharm Inc (NQ: CPRX )
20.38
-0.17
(-0.83%)
Streaming Delayed Price
Updated: 10:00 AM EDT, Aug 27, 2024
Add to My Watchlist
All News about Catalyst Pharm Inc
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://investorplace.com/wp-content/uploads/2020/09/biotech-stocks.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Catalyst Pharmaceuticals
February 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/05/eye-5248678.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://g.foolcdn.com/editorial/images/767685/investor-inspects-papers-on-a-couch.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image33.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/22/jim-cramer2.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://g.foolcdn.com/editorial/images/760854/two-investors-consider-a-laptop.jpg)
![](https://g.foolcdn.com/editorial/images/760686/scientists-talking-about-antiviral-drug-in-laboratory.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering
January 09, 2024
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2024/01/05/image31.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/01/A1-010824-biotech-Gash.jpg)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/05/franklin_covey_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.